Rankings
▼
Calendar
TEVA FY 2010 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$35B
FY 2010 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$16.1B
+16.0% YoY
Gross Profit
$9.1B
56.2% margin
Operating Income
$3.9B
24.0% margin
Net Income
$3.3B
20.7% margin
EPS (Diluted)
$3.67
Cash Flow
Operating Cash Flow
$4.1B
Free Cash Flow
$3.4B
Stock-Based Comp.
$80M
Balance Sheet
Total Assets
$39.1B
Total Liabilities
$17.1B
Stockholders' Equity
$21.9B
Cash & Equivalents
$1.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16.1B
$13.9B
+16.0%
Gross Profit
$9.1B
$7.4B
+23.0%
Operating Income
$3.9B
$2.4B
+61.0%
Net Income
$3.3B
$2.0B
+66.5%
← FY 2009
All Quarters
FY 2011 →